GPER has also been shown to provide protection in a mouse model of multiple sclerosis30, to contribute to monocyte-dependent skin inflammation in response to serum from lupus patients, and to reverse peripheral immunosuppression in an ovariectomized mouse model of stroke33. Here, GPER1 is linked to systemic lupus erythematosus.